The announcement comes amid worries existing vaccines could be less effective against the heavily mutated strain
Covid booster shots delivered 71% to 75% protection against getting mild Covid symptoms from the omicron variant, according to a study the U.K. Health Security Agency released Friday, amid worries existing vaccines could be less effective against the heavily mutated strain.... [+]Among those who had received two doses of the AstraZeneca vaccine, a Pfizer-BioNTech booster increased vaccine effectiveness against the omicron variant to 71.4% two weeks after it was received — that figure was 75.
5% for people whose primary doses were the Pfizer-BioNTech vaccine, according to theTwo doses of the Pfizer-BioNTech vaccine followed by a Pfizer-BioNTech booster gave 92.6% protection against the delta variant, while two doses of the AstraZeneca jab followed by the Pfizer booster yielded 93.8% protection. The study has not yet been peer reviewed and excluded mixed primary doses.The agency predicted the omicron variant would make up more than half of all Covid cases in the U.K.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer says its COVID-19 booster shot offers protection against the Omicron variantPfizer says a booster dose of its COVID-19 vaccine may protect against the new Omicron variant, which early indications show might be more contagious.
続きを読む »
Covid Booster Shot Increases Vaccine Effectiveness To 71%-75% Against Omicron, U.K. Scientists SayThe omicron variant is expected to make up more than half of all Covid cases in the U.K. by mid-December, the agency said.
続きを読む »
Paper certificates for Covid-19 booster jabs in JerseyA digital certificate was launched in Jersey in October, but was forced to shut hours after opening.
続きを読む »
HHS Secretary Xavier Becerra: 16-17 Year Olds Are Now Eligible for COVID-19 Booster Shots.CDCgov now recommends that 16 and 17 year-olds get boosters if eligible after at least 6 months of completed Pfizer vaccination. Statement from HHS Secretary Xavier Becerra:
続きを読む »
FDA Greenlights Booster Shots Of Pfizer/BioNTech’s Covid Vaccine For 16 And 17-Year-OldsPfizer and BioNTech will also apply to the FDA to expand the approval of their companies' vaccine to include the third dose.
続きを読む »